| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARVINAS, INC. | Director | Common Stock | 26,045 | $250,552 | $9.62 | 25 Jun 2025 | Direct |
| ARVINAS, INC. | Director | Stock Option (right to buy) | 23,105 | $145,120 | $16.00 | 25 Jun 2025 | Direct |
| Codiak BioSciences, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 185,000 | 24 Jan 2023 | Direct | ||
| VBI Vaccines Inc/BC | Director | Option (Right to Buy Common Shares) | 75,000 | 27 Jan 2022 | Direct | ||
| Codiak BioSciences, Inc. | Chief Financial Officer | Restricted Stock Units | 15,224 | 16 Feb 2023 | Direct | ||
| Codiak BioSciences, Inc. | Chief Financial Officer | Common Stock | 0 | 28 Mar 2023 | Direct |